Philadelphia-Positive Acute Lymphoblastic Leukemia—Is Bone Marrow Transplant Still Necessary?
Open Access
- 31 January 2011
- journal article
- review article
- Published by Elsevier BV in Transplantation and Cellular Therapy
- Vol. 17 (1), S84-S88
- https://doi.org/10.1016/j.bbmt.2010.11.023
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome–positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International ALL Trial MRC UKALLXII/ECOG2993Blood, 2009
- BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of IkarosNature, 2008
- Reduced intensity conditioning allogeneic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow TransplantationHaematologica, 2008
- 369: Reduced-intensity stem cell transplantation for high-risk acute lymphoblastic leukemiaTransplantation and Cellular Therapy, 2007
- Imatinib plus steroids induces complete remissions and prolonged survival in elderly Philadelphia chromosome–positive patients with acute lymphoblastic leukemia without additional chemotherapy: results of the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) LAL0201-B protocolBlood, 2007
- Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome–positive acute lymphoblastic leukemia: results of the GRAAPH-2003 studyBlood, 2006
- Comparable results in patients with acute lymphoblastic leukemia after related and unrelated stem cell transplantationBone Marrow Transplantation, 2005
- Philadelphia positive acute lymphoblastic leukaemia of childhoodBritish Journal of Haematology, 2005
- Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylateBlood, 2004
- Nonmyeloablative stem cell transplantation in adults with high-risk ALL may be effective in early but not in advanced diseaseLeukemia, 2002